# Safety, Efficacy, and Pharmacokinetics of Adalimumab in Japanese Children With Juvenile Rheumatoid Arthritis

> **NCT00690573** · PHASE3 · COMPLETED · sponsor: **Abbott** · enrollment: 25 (actual)

## Conditions studied

- Juvenile Rheumatoid Arthritis

## Interventions

- **BIOLOGICAL:** Adalimumab

## Key facts

- **NCT ID:** NCT00690573
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2010-03
- **Final completion:** 2011-09
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2012-09-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00690573

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00690573, "Safety, Efficacy, and Pharmacokinetics of Adalimumab in Japanese Children With Juvenile Rheumatoid Arthritis". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00690573. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*